2:30–2:45 P.M.

Genomics and Regulatory Science

Michael Pacanowski
Team Leader, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

 
2:45–3:00 P.M.

BREAK

 
3:00–3:15 P.M.

Repurposing of Drugs

Christopher Austin
Director of the Division of Pre-Clinical Innovation; Scientific Director, NIH Center for Translational Therapeutics; National Center for Advancing Translational Sciences, National Institutes of Health

 
3:15–3:30 P.M.

Pharmacy Benefit Management and Pharmacogenomics

Felix W. Frueh
President, Medco Research Institute

 
3:30–4:15 P.M.

Discussion with Speakers and Attendees

 
4:15–5:30 P.M.

LEADING THE STRATEGY FOR PERSONALIZED MEDICINE: PHARMA, GOVERNMENT, ACADEMIA—HOW DO WE ALL WORK TOGETHER?

Session Moderator: Thomas Lehner,
National Institute of Mental Health, National Institutes of Health

Discussants:

Deborah Dunsire
President and Chief Executive Officer, Millennium: The Takeda Oncology Company



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement